AU2001253024A1 - Diagnosis and treatment of gastrointestinal disease - Google Patents

Diagnosis and treatment of gastrointestinal disease

Info

Publication number
AU2001253024A1
AU2001253024A1 AU2001253024A AU5302401A AU2001253024A1 AU 2001253024 A1 AU2001253024 A1 AU 2001253024A1 AU 2001253024 A AU2001253024 A AU 2001253024A AU 5302401 A AU5302401 A AU 5302401A AU 2001253024 A1 AU2001253024 A1 AU 2001253024A1
Authority
AU
Australia
Prior art keywords
diagnosis
treatment
gastrointestinal disease
gastrointestinal
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001253024A
Inventor
C. Timothy Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of AU2001253024A1 publication Critical patent/AU2001253024A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575Hormones
    • G01N2333/595Gastrins; Cholecystokinins [CCK]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/06Gastro-intestinal diseases
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/06Gastro-intestinal diseases
    • G01N2800/062Gastritis or peptic ulcer disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
AU2001253024A 2000-04-10 2001-03-30 Diagnosis and treatment of gastrointestinal disease Abandoned AU2001253024A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19591400P 2000-04-10 2000-04-10
US60/195,914 2000-04-10
PCT/US2001/010259 WO2001077685A2 (en) 2000-04-10 2001-03-30 Diagnosis and treatment of gastrointestinal disease

Publications (1)

Publication Number Publication Date
AU2001253024A1 true AU2001253024A1 (en) 2001-10-23

Family

ID=22723338

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001253024A Abandoned AU2001253024A1 (en) 2000-04-10 2001-03-30 Diagnosis and treatment of gastrointestinal disease

Country Status (3)

Country Link
AU (1) AU2001253024A1 (en)
CA (1) CA2404852A1 (en)
WO (1) WO2001077685A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4689597B2 (en) 2003-03-28 2011-05-25 レセプター バイオロジックス インク. Gastrin hormone immunoassay
FI119572B (en) * 2004-03-05 2008-12-31 Biohit Oyj A method for predicting gastric mucosa
EP3071206B1 (en) 2013-11-22 2021-02-17 CL Biosciences LLC Gastrin antagonists (eg yf476, netazepide) for treatment and prevention of osteoporosis
JP7469225B2 (en) 2017-06-15 2024-04-16 キャンサー アドヴァンシーズ インク. Compositions and methods for inducing humoral and cellular immunity against tumors and cancers - Patents.com

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993012817A1 (en) * 1991-12-20 1993-07-08 Warner-Lambert Company Therapeutic combinations useful in the treatment of gastroesophageal reflux disease
FI97304C (en) * 1994-11-16 1996-11-25 Locus Genex Oy A method for screening for the risk of gastric cancer

Also Published As

Publication number Publication date
WO2001077685A2 (en) 2001-10-18
CA2404852A1 (en) 2001-10-18
WO2001077685A3 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
AU2002323258A1 (en) Diagnosis and treatment of vascular disease
AU2001229442A1 (en) Improved endoscopic imaging and treatment of anatomic structures
AU2001275177A1 (en) Cardiac disease treatment and device
AU2001275176A1 (en) Cardiac disease treatment and device
AU2001253565A1 (en) Cardiac disease treatment and device
AU2002367535A1 (en) Diagnosis and treatment of vascular disease
AU2001281369A1 (en) Cardiac disease treatment and device
HUP0401127A3 (en) Treatment and diagnosis of macrophage disease
AU2001249835A1 (en) Diagnosis and treatment of alzheimer's disease
AU2003290548A1 (en) Prevention and treatment of synucleinopathic disease
AU2002326813A1 (en) Diagnosis and treatment of vascular disease
AU2002222108A1 (en) Diagnosis and treatment of alzheimer's disease
AU2003210266A1 (en) Treatment, diagnosis and imaging of disease
AU2002341880A1 (en) Diagnosis and treatment of vascular disease
AU2002341604A1 (en) Diagnosis and treatment of vascular disease
AU5550800A (en) Diagnosis and treatment of alzheimer's disease
GB9909392D0 (en) Treatment, imaging and diagnosis of disease
AU4654500A (en) Prevention, diagnosis and treatment of lyme disease
AU2001253024A1 (en) Diagnosis and treatment of gastrointestinal disease
IL151019A0 (en) Microcompetition and human disease
AU2001296477A1 (en) Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
EP1409734A4 (en) Diagnosis and treatment of cancer
AU2002319591A1 (en) Diagnosis and treatment of vascular disease
GB9908059D0 (en) Diagnosis and treatment of diseases
AU2001267177A1 (en) Diagnosis and treatment of herpes infections